期刊文献+

中国基因治疗专利分析 被引量:1

Analysis of Chinese Patent Application in Gene Therapy
下载PDF
导出
摘要 基因治疗是指基于修饰活细胞遗传物质而进行的医学干预,虽然在安全性问题上受到质疑,但其高效、特异的优点使其在肿瘤、遗传病、心脑血管疾病等疾病的治疗中有着良好的应用前景。作者采用在分类号和关键词检索的基础上人工进一步筛选和标引检索结果的方式,检索了中国专利检索系统文摘数据库(CPRS-ABS)中基因治疗专利申请,并分析了其申请年代、申请人、载体类型、疾病分类等方面信息,为我国基因治疗研究和专利申请提供了参考。 Gene therapy is medical intervention based on modified genetic material of living cells. Gene therapy isqueried for its safety, however, its advantages in efficiency and specificity have made good prospect in the treatmentof tumor, genetic disease and cardiovascular diseases. Authors searched patent applications in gene therapy in CPRS-ABS through further artificial screen and index based on a search by IPC class number and keywords, and analysedinformation on years, applicants, typies of vehicle, disease etc., which provides reference for research and patent ap-plication in gene therapy in China.
作者 张起 张蕾颖
出处 《河南科技》 2016年第6期66-69,共4页 Henan Science and Technology
关键词 基因治疗 载体 专利 gene therapy vehicle patent
  • 相关文献

参考文献6

二级参考文献93

  • 1杨仑,夏振华,陈剑,毛颖,徐朗莱.中国基因专利的数据挖掘[J].中国生物工程杂志,2006,26(11):91-96. 被引量:2
  • 2吴小兵.基因治疗研发和产业化发展策略[EB/OL].[2006-07-18].http://www.dxy.cn/portal/article/284/1307.html.
  • 3[1]Dai Y, Roman M, Naviaux RK, et al. Gene therapy via primary myoblasts :long term expression of factor Ⅸ protein following transplantation in vivo[J]. Proc Natl Acad Sci USA,1992, 89: 10892-10895.
  • 4[2]Naldini L, Blome V, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector[J]. Science, 1996, 272: 263-267.
  • 5[3]Blaese RM ,Culver KW, Miller AD, et al. T-lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years[J]. Science, 1995,270:475-480.
  • 6[4]Fisher K J, Choi H, Burda J, et al. Recombinant adennovirus delected of all viral genes for gene therapy of cystic fibrosis[J]. Virol, 1996,217: 11-22.
  • 7[5]During MJ , Naegele JR, O' Maller KL, et al. Long-term behavioral recovery in Pakinsonian rats by an HSV vector expressing tyrosine hydroxylase[J]. Science, 1994,266 : 1399-1403.
  • 8[6]Kaplitt MG , Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain[J]. Nat Genet, 1994,8:148-154.
  • 9[7]Grimm D, Kern A, Rittner K, et al. Novel tools for production and purification of recombinant adenoassociated virus vectors[J]. Hum Gene Ther, 1998,9: 2745-608.
  • 10[8]Xu R, Dring MJ. Recombinant AAV, a versatile vector for in vivo functional genomic studies in the mammalian CNS[J]. Nat Biotechnol,in press.

共引文献50

同被引文献7

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部